Translational Research Institute (TRI)

The Translational Research Institute (TRI) is a leading Australian medical research, development and translation facility. It is home to a broad range of cutting-edge research into cancer, chronic diseases, mental health conditions, immunology, genetics and more. TRI’s priority is partnering scientific development with clinicians and the MedTech sector to ensure new discoveries progress quickly and improve patient outcomes and commercial return. To this end, TRI is at the interface of science, medicine and industry. Our vision is Exceptional Science, Healthier Lives.

Situated on the Princess Alexandra Hospital precinct, TRI is a joint venture between Queensland Health, The University of Queensland, the Queensland University of Technology and Mater Research.

TRI houses more than 1000 leading researchers, support staff and students and has a community of bio-tech and med-tech start-up companies as well as industry bodies located on its campus. The Institute has two clinical trial facilities, one based at the PA Hospital and the other at the Centre for Children’s Health Research next to the Children’s Hospital.

GET INVOLVED